Literature DB >> 26655327

The autoimmune diseases of the eyes.

Francisco Assis de Andrade1, Savio Henrique Serafini Fiorot2, Eliezer Israel Benchimol3, Jacqueline Provenzano2, Vanessa Jandre Martins4, Roger Abramino Levy5.   

Abstract

The eye is divided anatomically in three layers: an outer or fibrous layer (cornea/sclera), middle or vascular layer (uvea - iris, ciliary body, and choroid) and an inner or sensorineural layer (retina). They compose the several anatomic and functional layers that enable the immune protection of the eye. The first layer involves an intact anatomic border with the blood-ocular barrier and immunosuppressive neuropeptides in the native aqueous humor. The second layer trusts on the capability of the eye to reestablish an immunosuppressive micro-environment by activating latent TGF-β and reestablishing the anterior chamber-associated immune deviation. The third layer involves a mechanism that is not yet completely recognized, but that has the ability to overcome a predominantly Th1 intraocular immune response and to reestablish anterior chamber-associated immune deviation. Understanding the comprehensive mechanisms of these pathways, will lead to the development of new treatments strategies in order to prevent damage to the eye from persistent or exacerbated inflammation, directed at first to pathogens, but that may develop an autoimmune reaction.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anterior chamber-associated immune deviation (ACAID); Blood ocular barrier; Ocular immune privilege; Pigmented epithelial cells; Retinal imaging

Mesh:

Substances:

Year:  2015        PMID: 26655327     DOI: 10.1016/j.autrev.2015.12.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

Review 1.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

Review 2.  The role of pro-resolving lipid mediators in ocular diseases.

Authors:  Jessica Wei; Karsten Gronert
Journal:  Mol Aspects Med       Date:  2017-04-06

3.  Selective permeability of mouse blood-aqueous barrier as determined by 15N-heavy isotope tracing and mass spectrometry.

Authors:  Pan Liu; Benjamin R Thomson; Natalia Khalatyan; Liang Feng; Xiaorong Liu; Jeffrey N Savas; Susan E Quaggin; Jing Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

Review 4.  Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.

Authors:  Yu-Wen Zhou; Qian Xu; Yan Wang; Ruo-Lan Xia; Ji-Yan Liu; Xue-Lei Ma
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

Review 5.  Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Authors:  Taekyun Shin; Meejung Ahn; Jeongtae Kim; Kyungsook Jung; Changjong Moon; Moon-Doo Kim
Journal:  Mol Neurobiol       Date:  2021-03-20       Impact factor: 5.590

6.  Novel Classification of Early-stage Systemic Hypertensive Changes in Human Retina Based on OCTA Measurement of Choriocapillaris.

Authors:  Kei Takayama; Hiroki Kaneko; Yasuki Ito; Keiko Kataoka; Takeshi Iwase; Tetsuhiro Yasuma; Toshiyuki Matsuura; Taichi Tsunekawa; Hideyuki Shimizu; Ayana Suzumura; Eimei Ra; Tomohiko Akahori; Hiroko Terasaki
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

Review 7.  Recent advances of exosomes in immune-mediated eye diseases.

Authors:  Na Li; Lu Zhao; Yankai Wei; Vicki L Ea; Hong Nian; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2019-08-30       Impact factor: 6.832

8.  Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.

Authors:  Sara J Haug; Doan Luong Hien; Gunay Uludag; Than Trong Tuong Ngoc; Sherin Lajevardi; M Sohail Halim; Yasir J Sepah; Diana V Do; Arshad M Khanani
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-31

Review 9.  Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.